Essity AB (publ) at Barclays Global Consumer Staples Conference (Virtual) Transcript
As one of the world's largest tissue and hygiene companies, Essity is seeing volume growth rebound as the world emerges from lockdown, but rising input costs have begun to put pressure on gross margins. Essity has continued with active capital allocation this year, buying out other shareholders in its Lat Am JV, Familia, and its Australian associate, Asaleo. We're delighted to be joined by Magnus Groth, the CEO of Essity, and he will update us on how things are going. Magnus, thank you so much for joining.
()- -
Thank you. Good to be here.
Questions & Answers
So just to kick off. I mean you've got a portfolio that covers most tissue and hygiene categories across most geographies and most channels. When you think about the growth engines over the next few years, where do you see
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
